TokenPost topic

Latigo Biotherapeutics

1 TokenPost story is tagged Latigo Biotherapeutics. The newest appear first.

Latest Latigo Biotherapeutics stories

• Latigo Biotherapeutics’ Q3 Loss Per Share Beats Estimate by $0.12

  The company expects $401 million in cash and cash equivalents to fund operations into 2029.

  Nov 7, 2026, 5:18 AM EST · Business